文献速递肝胆胰外科

腹腔镜与开腹肝切除治疗肝细胞癌的系统综述与荟萃分析

Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2019-05-28

结果显示LLR在输血率、住院天数、30天死亡率及并发症发生率方面显著低于OLR,且1年与5年总生存率显著更高;手术时间、切缘距离及R0切除率无显著差异。作者认为仍需随机对照试验确认优劣。

要点

  • LLR组输血率、住院天数、30天死亡率及并发症发生率均显著低于OLR组。
  • LLR组1年与5年总生存率显著高于OLR组。
  • 手术时间、切缘距离及R0切除率两组无显著差异。

核心结论

  • 对于肝细胞癌,LLR在术中失血、输血率、住院天数、30天死亡率和并发症方面优于OLR。
  • LLR与OLR在手术时间、切缘距离和R0切除率上无显著差异。
  • LLR的1年及5年总生存率显著高于OLR。
  • 仍需随机对照试验确认两种策略的优劣。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE和Cochrane Central Register of Controlled Trials数据库。

主要发现

  • 输血率:LLR显著低于OLR(OR 0.45;95%CI 0.30-0.69;P=0.001;I2=55.83%)。
  • 住院天数:LLR显著短于OLR(MD -3.87;95%CI -4.86至-2.89;P=0.001;I2=87.35%)。
  • 30天死亡率:LLR显著低于OLR(OR 0.32;95%CI 0.16-0.66;P=0.001;I2=0%)。
  • 并发症发生率:LLR显著低于OLR(OR 0.42;95%CI 0.34-0.52;P=0.001;I2=39.64%)。
  • 手术时间、切缘距离、R0切除率两组无显著差异(分别为MD 18.29;95%CI -1.58至38.15;P=0.07;I2=91.73%;MD 0.04;95%CI -0.06至0.14;P=0.41;I2=48.03%;OR 1.31;95%CI 0.98-1.76;P=0.07;I2=0%)。

关键数值与推荐

  • 1年总生存率:LLR显著高于OLR(OR 1.45;95%CI 1.06-1.99;P=0.02;I2=25.59%)。
  • 5年总生存率:LLR显著高于OLR(OR 1.36;95%CI 1.07-1.72;P=0.01;I2=14.88%)。

临床怎么用

  • 对于适合腹腔镜手术的肝细胞癌患者,LLR可减少输血、缩短住院时间并降低30天死亡率和并发症。
  • LLR与OLR在肿瘤学切除质量(切缘距离、R0切除率)上无显著差异,但需注意研究异质性。
  • 临床决策应结合患者具体情况和术者经验,并认识到仍需随机对照试验证据。

局限性

  • 纳入研究多为观察性研究,存在异质性(如住院天数I2=87.35%,手术时间I2=91.73%)。
  • 作者明确指出需要随机对照试验来确认LLR或OLR的优越性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have been conducted comparing laparoscopic liver resection (LLR) versus open liver resection (OLR) for hepatocellular carcinoma (HCC), however, the optimal therapeutic approach has not been established. Therefore, we conducted a systematic review and meta-analysis of studies comparing LLR versus OLR for HCC. METHODS: MEDLINE and Cochrane Central Register of Controlled Trials database were systematically searched for relevant studies. RESULTS: Fifty-one studies were identified including a total of 6812 patients (2786 patients underwent LLR and 4026 patients were subjected to OLR). Blood transfusion rate, hospital stay in days, 30-days mortality rate and morbidity were significantly lower in LLR comparing with OLR (odds ratio (OR) 0.45; 95% confidence interval (CI) 0.30-0.69; P = 0.001; I2 = 55.83%), (MD - 3.87; 95% CI - 4.86 to - 2.89; P = 0.001; I2 = 87.35%), (OR 0.32; 95% CI 0.16-0.66; P = 0.001; I2 = 0%), and (OR 0.42; 95% CI 0.34-0.52; P = 0.001; I2 = 39.64), respectively. There was no significant difference between LLR and OLR regarding the operative time in minutes, resection margin in centimeter and R0 resection (MD 18.29; 95% CI - 1.58 to 38.15; p = 0.07; I2 = 91.73%), (MD 0.04; 95% CI - 0.06 to 0.14; P = 0.41; I2 = 48.03%) and (OR 1.31; 95% CI 0.98-1.76; P = 0.07; I2 = 0%), respectively. The 1-year overall survival (1-OS) and 5-OS rates were significantly higher in LLR comparing with OLR (OR 1.45; 95% CI 1.06-1.99; P = 0.02; I2 = 25.59%) and (OR 1.36; 95% CI 1.07-1.72; P = 0.01; I2 = 14.88%), respectively. CONCLUSION: LLR is superior to OLR regarding intraoperative blood loss, blood transfusion rate, hospital stay in days, 30-days mortality and morbidity, however, randomized controlled trials are needed to identify the superiority of either strategy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xiangfei M, Yinzhe X, Yingwei P, et al. Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis. Surg Endosc. 2019. PMID: 31139980. doi:10.1007/s00464-019-06781-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。